201
|
Odenheimer S, Goyal D, Jones VG, Rosenblum R, Ho L, Chan AS. Patient Acceptance of Remote Scribing Powered by Google Glass in Outpatient Dermatology: Cross-Sectional Study. J Med Internet Res 2018; 20:e10762. [PMID: 29929947 PMCID: PMC6035348 DOI: 10.2196/10762] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2018] [Revised: 05/11/2018] [Accepted: 05/11/2018] [Indexed: 01/23/2023] Open
Abstract
BACKGROUND The ubiquitous use of electronic health records (EHRs) during medical office visits using a computer monitor and keyboard can be distracting and can disrupt patient-health care provider (HCP) nonverbal eye contact cues, which are integral to effective communication. Provider use of a remote medical scribe with face-mounted technology (FMT), such as Google Glass, may preserve patient-HCP communication dynamics in health care settings by allowing providers to maintain direct eye contact with their patients while still having access to the patient's relevant EHR information. The medical scribe is able to chart patient encounters in real-time working in an offsite location, document the visit directly into EHR, and free HCP to focus only on the patient. OBJECTIVE The purpose of this study was to examine patient perceptions of their interactions with an HCP who used FMT with a remote medical scribe during office visits. This includes an examination of any association between patient privacy and trust in their HCP when FMT is used in the medical office setting. METHODS For this descriptive, cross-sectional study, a convenience sample of patients was recruited from an outpatient dermatology clinic in Northern California. Participants provided demographic data and completed a 12-item questionnaire to assess their familiarity, comfort, privacy, and perceptions following routine office visits with an HCP where FMT was used to document the clinical encounter. Data were analyzed using appropriate descriptive and inferential statistics. RESULTS Over half of the 170 study participants were female (102/170, 59.4%), 60.0% were Caucasian (102/170), 24.1% were Asian (41/170), and 88.8% were college-educated (151/170). Age ranged between 18 and 90 years (mean 50.5, SD 17.4). The majority of participants (118/170, 69.4%) were familiar with FMT, not concerned with privacy issues (132/170, 77.6%), and stated that the use of FMT did not affect their trust in their HCP (139/170, 81.8%). Moreover, participants comfortable with the use of FMT were less likely to be concerned about privacy (P<.001) and participants who trusted their HCP were less likely to be concerned about their HCP using Google Glass (P<.009). Almost one-third of them self-identified as early technology adopters (49/170, 28.8%) and 87% (148/170) preferred their HCP using FMT if it delivered better care. CONCLUSIONS Our study findings support the patient acceptance of Google Glass use for outpatient dermatology visits. Future research should explore the use of FMT in other areas of health care and strive to include a socioeconomically diverse patient population in study samples.
Collapse
Affiliation(s)
- Sandra Odenheimer
- Palo Alto Medical Foundation, Sunnyvale, CA, United States.,The Valley Foundation School of Nursing, San Jose State University, San Jose, CA, United States.,Department of Nursing, California State University Fresno, Fresno, CA, United States
| | - Deepika Goyal
- The Valley Foundation School of Nursing, San Jose State University, San Jose, CA, United States.,Department of Nursing, California State University Fresno, Fresno, CA, United States
| | - Veena Goel Jones
- Office of Patient Experience, Sutter Health, Sacramento, CA, United States.,Palo Alto Medical Foundation Research Institute, Palo Alto, CA, United States
| | - Ruth Rosenblum
- The Valley Foundation School of Nursing, San Jose State University, San Jose, CA, United States.,Department of Nursing, California State University Fresno, Fresno, CA, United States
| | - Lam Ho
- Office of Patient Experience, Sutter Health, Sacramento, CA, United States
| | - Albert S Chan
- Office of Patient Experience, Sutter Health, Sacramento, CA, United States.,Palo Alto Medical Foundation Research Institute, Palo Alto, CA, United States
| |
Collapse
|
202
|
Kirkwood MK, Hanley A, Bruinooge SS, Garrett-Mayer E, Levit LA, Schenkel C, Seid JE, Polite BN, Schilsky RL. The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey. J Oncol Pract 2018; 14:e412-e420. [PMID: 29906211 DOI: 10.1200/jop.18.00149] [Citation(s) in RCA: 104] [Impact Index Per Article: 17.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PURPOSE To describe the US hematology and medical oncology practice landscape and to report findings of the sixth annual ASCO Oncology Practice Census survey. PARTICIPANTS AND METHODS ASCO used Medicare Physician Compare data to characterize oncology practices in the United States. Practice size, number of care sites, and geographic distribution were determined. Trends in the number and size of practices from 2013 to 2017 were examined. All US oncology practices were targeted for the survey; survey responses were linked to the practices identified from Physician Compare to augment results and assess generalizability. RESULTS More than 2,200 hematology/oncology practices provided care to adult patients in 2017. We observed annual decreases in the number of practices and annual increases in practice size. Of the 2017 practices, 394 (18%) completed the survey and accounted for 58% of the US hematologist/oncologist workforce (n = 7,203). Respondents tended to be larger and encompass more sites of care than nonrespondents. Surveyed practices cited payers (58%), competition (38%), and staffing (37%) as primary sources of strain. Prior authorization was dominant among payer pressures (78%). Electronic health records remained a burden on practices, with only 15% reporting full interoperability. CONCLUSION The results of ASCO's 2017 survey indicate that oncology practices are challenged by day-to-day operations, often related to payment, reimbursement, and competition. Our findings likely represent conservative estimates of such burdens because they are driven by responses from midsized to large-sized organizations, which have lower relative administrative burden, greater market influence, and potentially better ability to adapt in a changing health care environment.
Collapse
Affiliation(s)
- M Kelsey Kirkwood
- American Society of Clinical Oncology, Alexandria VA; Great Lakes Cancer Management Specialists, Macomb, MI; and University of Chicago, Chicago, IL
| | - Amy Hanley
- American Society of Clinical Oncology, Alexandria VA; Great Lakes Cancer Management Specialists, Macomb, MI; and University of Chicago, Chicago, IL
| | - Suanna S Bruinooge
- American Society of Clinical Oncology, Alexandria VA; Great Lakes Cancer Management Specialists, Macomb, MI; and University of Chicago, Chicago, IL
| | - Elizabeth Garrett-Mayer
- American Society of Clinical Oncology, Alexandria VA; Great Lakes Cancer Management Specialists, Macomb, MI; and University of Chicago, Chicago, IL
| | - Laura A Levit
- American Society of Clinical Oncology, Alexandria VA; Great Lakes Cancer Management Specialists, Macomb, MI; and University of Chicago, Chicago, IL
| | - Caroline Schenkel
- American Society of Clinical Oncology, Alexandria VA; Great Lakes Cancer Management Specialists, Macomb, MI; and University of Chicago, Chicago, IL
| | - Jerome E Seid
- American Society of Clinical Oncology, Alexandria VA; Great Lakes Cancer Management Specialists, Macomb, MI; and University of Chicago, Chicago, IL
| | - Blase N Polite
- American Society of Clinical Oncology, Alexandria VA; Great Lakes Cancer Management Specialists, Macomb, MI; and University of Chicago, Chicago, IL
| | - Richard L Schilsky
- American Society of Clinical Oncology, Alexandria VA; Great Lakes Cancer Management Specialists, Macomb, MI; and University of Chicago, Chicago, IL
| |
Collapse
|
209
|
Read-Brown S, Hribar MR, Reznick LG, Lombardi LH, Parikh M, Chamberlain WD, Bailey ST, Wallace JB, Yackel TR, Chiang MF. Time Requirements for Electronic Health Record Use in an Academic Ophthalmology Center. JAMA Ophthalmol 2017; 135:1250-1257. [PMID: 29049512 DOI: 10.1001/jamaophthalmol.2017.4187] [Citation(s) in RCA: 60] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Importance Electronic health record (EHR) systems have transformed the practice of medicine. However, physicians have raised concerns that EHR time requirements have negatively affected their productivity. Meanwhile, evolving approaches toward physician reimbursement will require additional documentation to measure quality and cost of care. To date, little quantitative analysis has rigorously studied these topics. Objective To examine ophthalmologist time requirements for EHR use. Design, Setting, and Participants A single-center cohort study was conducted between September 1, 2013, and December 31, 2016, among 27 stable departmental ophthalmologists (defined as attending ophthalmologists who worked at the study institution for ≥6 months before and after the study period). Ophthalmologists who did not have a standard clinical practice or who did not use the EHR were excluded. Exposures Time stamps from the medical record and EHR audit log were analyzed to measure the length of time required by ophthalmologists for EHR use. Ophthalmologists underwent manual time-motion observation to measure the length of time spent directly with patients on the following 3 activities: EHR use, conversation, and examination. Main Outcomes and Measures The study outcomes were time spent by ophthalmologists directly with patients on EHR use, conversation, and examination as well as total time required by ophthalmologists for EHR use. Results Among the 27 ophthalmologists in this study (10 women and 17 men; mean [SD] age, 47.3 [10.7] years [median, 44; range, 34-73 years]) the mean (SD) total ophthalmologist examination time was 11.2 (6.3) minutes per patient, of which 3.0 (1.8) minutes (27% of the examination time) were spent on EHR use, 4.7 (4.2) minutes (42%) on conversation, and 3.5 (2.3) minutes (31%) on examination. Mean (SD) total ophthalmologist time spent using the EHR was 10.8 (5.0) minutes per encounter (range, 5.8-28.6 minutes). The typical ophthalmologist spent 3.7 hours using the EHR for a full day of clinic: 2.1 hours during examinations and 1.6 hours outside the clinic session. Linear mixed effects models showed a positive association between EHR use and billing level and a negative association between EHR use per encounter and clinic volume. Each additional encounter per clinic was associated with a decrease of 1.7 minutes (95% CI, -4.3 to 1.0) of EHR use time per encounter for ophthalmologists with high mean billing levels (adjusted R2 = 0.42; P = .01). Conclusions and Relevance Ophthalmologists have limited time with patients during office visits, and EHR use requires a substantial portion of that time. There is variability in EHR use patterns among ophthalmologists.
Collapse
Affiliation(s)
- Sarah Read-Brown
- Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland
| | - Michelle R Hribar
- Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland
| | - Leah G Reznick
- Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland
| | - Lorinna H Lombardi
- Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland
| | - Mansi Parikh
- Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland
| | - Winston D Chamberlain
- Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland
| | - Steven T Bailey
- Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland
| | - Jessica B Wallace
- Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland
| | - Thomas R Yackel
- Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland
| | - Michael F Chiang
- Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland.,Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland
| |
Collapse
|
211
|
Miyasaki JM, Rheaume C, Gulya L, Ellenstein A, Schwarz HB, Vidic TR, Shanafelt TD, Cascino TL, Keran CM, Busis NA. Qualitative study of burnout, career satisfaction, and well-being among US neurologists in 2016. Neurology 2017; 89:1730-1738. [PMID: 28931640 DOI: 10.1212/wnl.0000000000004526] [Citation(s) in RCA: 45] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2017] [Accepted: 07/10/2017] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To understand the experience and identify drivers and mitigating factors of burnout and well-being among US neurologists. METHODS Inductive data analysis was applied to free text comments (n = 676) from the 2016 American Academy of Neurology survey of burnout, career satisfaction, and well-being. RESULTS Respondents providing comments were significantly more likely to be older, owners/partners of their practice, solo practitioners, and compensated by production than those not commenting. The 4 identified themes were (1) policies and people affecting neurologists (government and insurance mandates, remuneration, recertification, leadership); (2) workload and work-life balance (workload, electronic health record [EHR], work-life balance); (3) engagement, professionalism, work domains specific to neurology; and (4) solutions (systemic and individual), advocacy, other. Neurologists mentioned workload > professional identity > time spent on insurance and government mandates when describing burnout. Neurologists' patient and clerical workload increased work hours or work brought home, resulting in poor work-life balance. EHR and expectations of high patient volumes by administrators impeded quality of patient care. As a result, many neurologists reduced work hours and call provision and considered early retirement. CONCLUSIONS Our results further characterize burnout among US neurologists through respondents' own voices. They clarify the meaning respondents attributed to ambiguous survey questions and highlight the barriers neurologists must overcome to practice their chosen specialty, including multiple regulatory hassles and increased work hours. Erosion of professionalism by external factors was a common issue. Our findings can provide strategic direction for advocacy and programs to prevent and mitigate neurologist burnout and promote well-being and engagement.
Collapse
Affiliation(s)
- Janis M Miyasaki
- From the Department of Medicine, Division of Neurology (J.M.M.), University of Alberta, Edmonton, Canada; Member Insights Department (C.R., L.G., C.M.K.), American Academy of Neurology, Minneapolis, MN; Department of Neurology (A.E.), George Washington University, Washington, DC; Department of Neurology (H.B.S.), University of Rochester Medical Center, NY; Department of Neurology (T.R.V.), Elkhart Clinic, IN; Departments of Medicine, Hematology and Oncology (T.D.S.) and Neurology (T.L.C.), Mayo Clinic, Rochester, NY; and Department of Neurology (N.A.B.), University of Pittsburgh School of Medicine, PA.
| | - Carol Rheaume
- From the Department of Medicine, Division of Neurology (J.M.M.), University of Alberta, Edmonton, Canada; Member Insights Department (C.R., L.G., C.M.K.), American Academy of Neurology, Minneapolis, MN; Department of Neurology (A.E.), George Washington University, Washington, DC; Department of Neurology (H.B.S.), University of Rochester Medical Center, NY; Department of Neurology (T.R.V.), Elkhart Clinic, IN; Departments of Medicine, Hematology and Oncology (T.D.S.) and Neurology (T.L.C.), Mayo Clinic, Rochester, NY; and Department of Neurology (N.A.B.), University of Pittsburgh School of Medicine, PA
| | - Lisa Gulya
- From the Department of Medicine, Division of Neurology (J.M.M.), University of Alberta, Edmonton, Canada; Member Insights Department (C.R., L.G., C.M.K.), American Academy of Neurology, Minneapolis, MN; Department of Neurology (A.E.), George Washington University, Washington, DC; Department of Neurology (H.B.S.), University of Rochester Medical Center, NY; Department of Neurology (T.R.V.), Elkhart Clinic, IN; Departments of Medicine, Hematology and Oncology (T.D.S.) and Neurology (T.L.C.), Mayo Clinic, Rochester, NY; and Department of Neurology (N.A.B.), University of Pittsburgh School of Medicine, PA
| | - Aviva Ellenstein
- From the Department of Medicine, Division of Neurology (J.M.M.), University of Alberta, Edmonton, Canada; Member Insights Department (C.R., L.G., C.M.K.), American Academy of Neurology, Minneapolis, MN; Department of Neurology (A.E.), George Washington University, Washington, DC; Department of Neurology (H.B.S.), University of Rochester Medical Center, NY; Department of Neurology (T.R.V.), Elkhart Clinic, IN; Departments of Medicine, Hematology and Oncology (T.D.S.) and Neurology (T.L.C.), Mayo Clinic, Rochester, NY; and Department of Neurology (N.A.B.), University of Pittsburgh School of Medicine, PA
| | - Heidi B Schwarz
- From the Department of Medicine, Division of Neurology (J.M.M.), University of Alberta, Edmonton, Canada; Member Insights Department (C.R., L.G., C.M.K.), American Academy of Neurology, Minneapolis, MN; Department of Neurology (A.E.), George Washington University, Washington, DC; Department of Neurology (H.B.S.), University of Rochester Medical Center, NY; Department of Neurology (T.R.V.), Elkhart Clinic, IN; Departments of Medicine, Hematology and Oncology (T.D.S.) and Neurology (T.L.C.), Mayo Clinic, Rochester, NY; and Department of Neurology (N.A.B.), University of Pittsburgh School of Medicine, PA
| | - Thomas R Vidic
- From the Department of Medicine, Division of Neurology (J.M.M.), University of Alberta, Edmonton, Canada; Member Insights Department (C.R., L.G., C.M.K.), American Academy of Neurology, Minneapolis, MN; Department of Neurology (A.E.), George Washington University, Washington, DC; Department of Neurology (H.B.S.), University of Rochester Medical Center, NY; Department of Neurology (T.R.V.), Elkhart Clinic, IN; Departments of Medicine, Hematology and Oncology (T.D.S.) and Neurology (T.L.C.), Mayo Clinic, Rochester, NY; and Department of Neurology (N.A.B.), University of Pittsburgh School of Medicine, PA
| | - Tait D Shanafelt
- From the Department of Medicine, Division of Neurology (J.M.M.), University of Alberta, Edmonton, Canada; Member Insights Department (C.R., L.G., C.M.K.), American Academy of Neurology, Minneapolis, MN; Department of Neurology (A.E.), George Washington University, Washington, DC; Department of Neurology (H.B.S.), University of Rochester Medical Center, NY; Department of Neurology (T.R.V.), Elkhart Clinic, IN; Departments of Medicine, Hematology and Oncology (T.D.S.) and Neurology (T.L.C.), Mayo Clinic, Rochester, NY; and Department of Neurology (N.A.B.), University of Pittsburgh School of Medicine, PA
| | - Terrence L Cascino
- From the Department of Medicine, Division of Neurology (J.M.M.), University of Alberta, Edmonton, Canada; Member Insights Department (C.R., L.G., C.M.K.), American Academy of Neurology, Minneapolis, MN; Department of Neurology (A.E.), George Washington University, Washington, DC; Department of Neurology (H.B.S.), University of Rochester Medical Center, NY; Department of Neurology (T.R.V.), Elkhart Clinic, IN; Departments of Medicine, Hematology and Oncology (T.D.S.) and Neurology (T.L.C.), Mayo Clinic, Rochester, NY; and Department of Neurology (N.A.B.), University of Pittsburgh School of Medicine, PA
| | - Chris M Keran
- From the Department of Medicine, Division of Neurology (J.M.M.), University of Alberta, Edmonton, Canada; Member Insights Department (C.R., L.G., C.M.K.), American Academy of Neurology, Minneapolis, MN; Department of Neurology (A.E.), George Washington University, Washington, DC; Department of Neurology (H.B.S.), University of Rochester Medical Center, NY; Department of Neurology (T.R.V.), Elkhart Clinic, IN; Departments of Medicine, Hematology and Oncology (T.D.S.) and Neurology (T.L.C.), Mayo Clinic, Rochester, NY; and Department of Neurology (N.A.B.), University of Pittsburgh School of Medicine, PA
| | - Neil A Busis
- From the Department of Medicine, Division of Neurology (J.M.M.), University of Alberta, Edmonton, Canada; Member Insights Department (C.R., L.G., C.M.K.), American Academy of Neurology, Minneapolis, MN; Department of Neurology (A.E.), George Washington University, Washington, DC; Department of Neurology (H.B.S.), University of Rochester Medical Center, NY; Department of Neurology (T.R.V.), Elkhart Clinic, IN; Departments of Medicine, Hematology and Oncology (T.D.S.) and Neurology (T.L.C.), Mayo Clinic, Rochester, NY; and Department of Neurology (N.A.B.), University of Pittsburgh School of Medicine, PA
| |
Collapse
|